Menu
GeneBe

ELN

elastin

Basic information

Region (hg38): 7:74027788-74069907

Links

ENSG00000049540NCBI:2006OMIM:130160HGNC:3327Uniprot:P15502AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • supravalvular aortic stenosis (Definitive), mode of inheritance: AD
  • cutis laxa, autosomal dominant 1 (Strong), mode of inheritance: AD
  • cutis laxa, autosomal dominant 1 (Strong), mode of inheritance: AD
  • cutis laxa, autosomal dominant 1 (Strong), mode of inheritance: AD
  • supravalvular aortic stenosis (Definitive), mode of inheritance: AD
  • cutis laxa, autosomal dominant 1 (Definitive), mode of inheritance: AD
  • supravalvular aortic stenosis (Supportive), mode of inheritance: AD
  • autosomal dominant cutis laxa (Supportive), mode of inheritance: AD
  • cutis laxa, autosomal dominant 1 (Strong), mode of inheritance: AD
  • supravalvular aortic stenosis (Strong), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Cutis laxa, autosomal dominant 1; Supravalvular aortic stenosisADCardiovascularIn Cutis laxa, cardiovascular anomalies (eg, aortic aneuryms and pulmonary artery stenosis) are frequent, and surveillance to allow efficient detection and treatment/precautionary measures may be beneficial; In supravalvular aortic stenosis, there is a wide range of severity, including sudden infant death, and early diagnosis and treatment (eg, with surgery in some individuals) may reduce morbidity and mortalityCardiovascular; Dermatologic; Gastrointestinal; Genitourinary; Musculoskeletal; Pulmonary5046633; 8475063; 8362925; 8364568; 8091333; 8132745; 8541862; 9215670; 9215671; 9873040; 11175284; 15955094; 16085695; 18348261; 19844261
Individuals with Cutis Laxa may have a clinically recognizable phenotype,

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ELN gene.

  • Supravalvar aortic stenosis (641 variants)
  • not provided (310 variants)
  • Cutis laxa, autosomal dominant 1 (96 variants)
  • not specified (68 variants)
  • Inborn genetic diseases (40 variants)
  • Cutis laxa, autosomal dominant (21 variants)
  • ELN-related condition (21 variants)
  • Cutis laxa, autosomal dominant 1;Williams syndrome;Supravalvar aortic stenosis (6 variants)
  • Williams syndrome (5 variants)
  • Supravalvar aortic stenosis;Cutis laxa, autosomal dominant 1;Williams syndrome (4 variants)
  • Williams syndrome;Cutis laxa, autosomal dominant 1;Supravalvar aortic stenosis (3 variants)
  • Cutis laxa, autosomal dominant 1;Supravalvar aortic stenosis;Williams syndrome (3 variants)
  • Williams syndrome;Supravalvar aortic stenosis;Cutis laxa, autosomal dominant 1 (2 variants)
  • See cases (2 variants)
  • Cutis laxa, autosomal dominant 1;Supravalvar aortic stenosis (2 variants)
  • Hypertelorism;Dural ectasia;Venous malformation;Abnormal digit morphology (1 variants)
  • Vascular dilatation;Ascending tubular aorta aneurysm (1 variants)
  • Familial thoracic aortic aneurysm and aortic dissection (1 variants)
  • Familial atrioventricular septal defect (1 variants)
  • 8 conditions (1 variants)
  • Stroke disorder (1 variants)
  • Supravalvar aortic stenosis;Cutis laxa, autosomal dominant 1 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ELN gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
3
clinvar
101
clinvar
4
clinvar
109
missense
3
clinvar
2
clinvar
212
clinvar
15
clinvar
5
clinvar
237
nonsense
17
clinvar
5
clinvar
22
start loss
2
clinvar
2
frameshift
58
clinvar
13
clinvar
71
inframe indel
20
clinvar
2
clinvar
22
splice donor/acceptor (+/-2bp)
12
clinvar
19
clinvar
9
clinvar
40
splice region
1
29
32
4
66
non coding
2
clinvar
53
clinvar
98
clinvar
43
clinvar
196
Total 92 42 297 216 52

Highest pathogenic variant AF is 0.0000131

Variants in ELN

This is a list of pathogenic ClinVar variants found in the ELN region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
7-74028118-G-C Supravalvar aortic stenosis • Cutis laxa, autosomal dominant • Williams syndrome;Cutis laxa, autosomal dominant 1;Supravalvar aortic stenosis Uncertain significance (Oct 08, 2021)360633
7-74028150-C-T Supravalvar aortic stenosis • Cutis laxa, autosomal dominant Benign (Jun 14, 2016)213168
7-74028151-G-C not specified Likely benign (Mar 27, 2017)508478
7-74028188-A-G Supravalvar aortic stenosis Pathogenic (Oct 05, 2023)2735031
7-74028189-T-C Supravalvar aortic stenosis Pathogenic/Likely pathogenic (Oct 03, 2023)213185
7-74028192-C-T Supravalvar aortic stenosis Uncertain significance (Jan 24, 2024)2073153
7-74028192-CG-C Supravalvar aortic stenosis Pathogenic (Jul 30, 2020)1072853
7-74028193-G-A Supravalvar aortic stenosis Likely benign (May 17, 2021)390210
7-74028193-G-C Supravalvar aortic stenosis Likely benign (Mar 11, 2022)2107196
7-74028195-G-A Supravalvar aortic stenosis Uncertain significance (Sep 18, 2023)1043351
7-74028201-C-G Supravalvar aortic stenosis Uncertain significance (Dec 04, 2022)2818445
7-74028202-G-A Supravalvar aortic stenosis • ELN-related disorder Likely benign (Nov 03, 2022)2714512
7-74028205-G-A Supravalvar aortic stenosis • ELN-related disorder Conflicting classifications of pathogenicity (Oct 05, 2023)568329
7-74028205-G-C Supravalvar aortic stenosis Likely benign (Jan 29, 2024)3013342
7-74028207-C-T Supravalvar aortic stenosis • Inborn genetic diseases Uncertain significance (Nov 24, 2023)1301436
7-74028213-C-T Supravalvar aortic stenosis Uncertain significance (Jul 17, 2023)2689013
7-74028214-G-A ELN-related disorder Likely benign (Nov 26, 2019)3048172
7-74028215-C-T Uncertain significance (Oct 06, 2022)2498057
7-74028220-C-T Supravalvar aortic stenosis Likely benign (Mar 17, 2023)2715649
7-74028221-G-A not specified • Supravalvar aortic stenosis Uncertain significance (Oct 14, 2023)228665
7-74028222-G-T Cutis laxa, autosomal dominant 1 • Supravalvar aortic stenosis • Cutis laxa, autosomal dominant 1;Williams syndrome;Supravalvar aortic stenosis Conflicting classifications of pathogenicity (Dec 26, 2023)872754
7-74028228-T-TC Supravalvar aortic stenosis Pathogenic (Mar 02, 2012)163381
7-74028229-C-T Supravalvar aortic stenosis Likely benign (Jan 05, 2017)453330
7-74028232-G-A Supravalvar aortic stenosis Likely benign (Aug 14, 2020)1143207
7-74028235-C-G Supravalvar aortic stenosis Likely benign (Jan 01, 2024)2139061

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ELNprotein_codingprotein_codingENST00000252034 3342119
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.14e-140.9471256650831257480.000330
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.04844274300.9930.00002694287
Missense in Polyphen
Synonymous-0.9471941781.090.00001381813
Loss of Function2.262945.40.6390.00000223538

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005590.000558
Ashkenazi Jewish0.000.00
East Asian0.0006520.000653
Finnish0.0008780.000878
European (Non-Finnish)0.0002640.000264
Middle Eastern0.0006520.000653
South Asian0.00009800.0000980
Other0.0003260.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Major structural protein of tissues such as aorta and nuchal ligament, which must expand rapidly and recover completely. Molecular determinant of the late arterial morphogenesis, stabilizing arterial structure by regulating proliferation and organization of vascular smooth muscle (By similarity). {ECO:0000250|UniProtKB:P54320}.;
Disease
DISEASE: Cutis laxa, autosomal dominant, 1 (ADCL1) [MIM:123700]: A connective tissue disorder characterized by loose, hyperextensible skin with decreased resilience and elasticity leading to a premature aged appearance. Face, hands, feet, joints, and torso may be differentially affected. Additional variable clinical features are gastrointestinal diverticula, hernia, and genital prolapse. Rare manifestations are pulmonary artery stenosis, aortic aneurysm, bronchiectasis, and emphysema. {ECO:0000269|PubMed:9873040}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Supravalvular aortic stenosis (SVAS) [MIM:185500]: Congenital narrowing of the ascending aorta which can occur sporadically, as an autosomal dominant condition, or as one component of Williams-Beuren syndrome. {ECO:0000269|PubMed:10942104}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=ELN is located in the Williams-Beuren syndrome (WBS) critical region. WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region. Haploinsufficiency of ELN may be the cause of certain cardiovascular and musculo-skeletal abnormalities observed in the disease (PubMed:8812460). {ECO:0000269|PubMed:8812460}.;
Pathway
Protein digestion and absorption - Homo sapiens (human);Lung fibrosis;Integrin (Consensus)

Intolerance Scores

loftool
0.815
rvis_EVS
-0.08
rvis_percentile_EVS
47.2

Haploinsufficiency Scores

pHI
0.931
hipred
N
hipred_score
0.366
ghis
0.655

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.750

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Eln
Phenotype
homeostasis/metabolism phenotype; muscle phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; skeleton phenotype;

Gene ontology

Biological process
outflow tract morphogenesis;aortic valve morphogenesis;respiratory gaseous exchange;blood circulation;cell population proliferation;animal organ morphogenesis;extracellular matrix organization
Cellular component
extracellular region;extracellular matrix;collagen-containing extracellular matrix;elastic fiber
Molecular function
extracellular matrix structural constituent;protein binding;extracellular matrix constituent conferring elasticity